Resources

Trachoma is the world’s leading infectious cause of preventable blindness. In Australia, it occurs primarily in remote and very remote Aboriginal communities in the Northern Territory, South Australia, and Western Australia. This document reports on the prevalence of trachoma in Australia in 2023.

An update from the Better Renal Services Steering Committee after their meeting on 20 November 2024.

Renal facility design guidelines developed to inform the infrastructure builds of the renal dialysis units under the Better Renal Services for First Nations People Budget Measure.

Trachoma is the world’s leading infectious cause of preventable blindness. In Australia, it occurs primarily in remote and very remote Aboriginal communities in the Northern Territory, South Australia, and Western Australia. This document reports on the prevalence of trachoma in Australia in 2021.

Trachoma is the world’s leading infectious cause of preventable blindness. In Australia, it occurs primarily in remote and very remote Aboriginal communities in the Northern Territory, South Australia, and Western Australia. This document reports on the prevalence of trachoma in Australia in 2020.

The National Eye and Tissue Sector Framework aims to guide the effective, evidence-based future operations and management of the Australian eye and tissue sector.

This document provides general feedback on the grant opportunity for Macular Disease – Consumer awareness and education – Population groups at risk for the information of grant applicants.

This report contains the final recommendations from the MBS Review Taskforce
following the consultation of the Ophthalmology Clinical Committee Report with
stakeholders.

This document outlines the Medicare Benefits Schedule (MBS) Taskforce’s
recommendations in response to the Ophthalmology Clinical Committee Report.

This document summarises the Medicare Benefits Schedule (MBS) Taskforce’s recommendations in response to the Optometry Clinical Committee report.

The National Strategic Action Plan for Macular Disease proposes a national response to macular disease across all levels of government in Australia. It recommends action in 4 major areas.

The Australian Government and state and territory governments’ collective response to PricewaterhouseCoopers’ analysis of the Australian Eye and Tissue Sector (2015).